474943-04-9
474943-04-9
Chemical Structure
C6 NBD Lactosylceramide
- CAS No.: 474943-04-9
- Formula:C42H69N5O16
- Molecular Weight:900.02
IUPAC Name: 4-nitrobenzoic-2,6-d2 acid
InChIKey: YITXFMQKMNZYOB-PVXRLSOKSA-N
SMILES: OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@@H]2O[C@@H]([C@@H]([C@@H]([C@H]2O)O)O)CO)O[C@H]1OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(CCCCCNC3=CC=C([N+]([O-])=O)C4=NON=C34)=O
Biological Activity: C6 NBD Lactosylceramide is a derivative of lactosylceramides, and can be used in lactosylceramide synthase assay as a fluorescent acceptor substrate. C6 NBD Lactosylceramide can also be used in cancer research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
C6 NBD Lactosylceramide | 98.0% | C6 NBD Lactosylceramide is a derivative of lactosylceramides, and can be used in lactosylceramide synthase assay as a fluorescent acceptor substrate. C6 NBD Lactosylceramide can also be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Samy A F Morad, et al. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer. Biochem Pharmacol. 2017 Apr 15;130:21-33. [Content Brief]
- [2]. J W Kok, et al. Sorting of sphingolipids in the endocytic pathway of HT29 cells. J Cell Biol. 1991 Jul;114(2):231-9. [Content Brief]
